Sakati–Nyhan–Tisdale syndrome
Sakati–Nyhan–Tisdale syndrome is a rare genetic disorder characterized by a variety of physical and developmental abnormalities. The syndrome was first described by Nadia Sakati, William Nyhan, and William Tisdale in 1971.
Symptoms and Signs[edit | edit source]
The symptoms of Sakati–Nyhan–Tisdale syndrome can vary greatly from person to person. However, common symptoms include microcephaly (small head size), micrognathia (small jaw), cleft palate, low-set ears, short stature, and intellectual disability. Some individuals may also have heart defects, kidney abnormalities, and skeletal abnormalities.
Causes[edit | edit source]
Sakati–Nyhan–Tisdale syndrome is caused by mutations in the genes that are involved in the development of various parts of the body. The exact genes involved are currently unknown. The syndrome is inherited in an autosomal recessive manner, which means both copies of the gene in each cell have mutations.
Diagnosis[edit | edit source]
The diagnosis of Sakati–Nyhan–Tisdale syndrome is based on the presence of characteristic clinical features. Genetic testing may be used to confirm the diagnosis and identify the specific gene mutation.
Treatment[edit | edit source]
There is currently no cure for Sakati–Nyhan–Tisdale syndrome. Treatment is symptomatic and supportive, and may include physical therapy, speech therapy, and educational support. Surgery may be required for certain physical abnormalities.
Prognosis[edit | edit source]
The prognosis for individuals with Sakati–Nyhan–Tisdale syndrome varies depending on the severity of the symptoms. Some individuals may have a normal lifespan, while others may have life-threatening complications.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Sakati–Nyhan–Tisdale syndrome Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD